Medpace Holdings, Inc. (MEDP)

USD 305.28

(2.54%)

Inventory Summary of Medpace Holdings, Inc.

  • Medpace Holdings, Inc.'s latest annual inventory in 2023 was 1.00 USD , down 0.0% from previous year.
  • Medpace Holdings, Inc.'s latest quarterly inventory in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Medpace Holdings, Inc. reported annual inventory of - USD in 2022, down 0.0% from previous year.
  • Medpace Holdings, Inc. reported annual inventory of - USD in 2021, down 0.0% from previous year.
  • Medpace Holdings, Inc. reported quarterly inventory of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Medpace Holdings, Inc. reported quarterly inventory of - USD for 2024 Q1, down -100.0% from previous quarter.

Annual Inventory Chart of Medpace Holdings, Inc. (2023 - 2014)

Historical Annual Inventory of Medpace Holdings, Inc. (2023 - 2014)

Year Inventory Inventory Growth
2023 1.00 USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD -100.0%
2019 1.00 USD -99.99%
2018 7000.00 USD 0.0%
2017 7000.00 USD -97.73%
2016 308 Thousand USD -89.22%
2015 2.85 Million USD 158.79%
2014 1.1 Million USD 0.0%

Peer Inventory Comparison of Medpace Holdings, Inc.

Name Inventory Inventory Difference
Aspira Women's Health Inc. 227 Thousand USD 100.0%
bioAffinity Technologies, Inc. 18.48 Thousand USD 99.995%
Intelligent Bio Solutions Inc. 777.53 Thousand USD 100.0%
Standard BioTools Inc. 20.53 Million USD 100.0%
Inotiv, Inc. 56.1 Million USD 100.0%
Prenetics Global Limited 3.12 Million USD 100.0%
Neuronetics, Inc. 8.09 Million USD 100.0%
Star Equity Holdings, Inc. 3.42 Million USD 100.0%
Castle Biosciences, Inc. 7.94 Million USD 100.0%
Psychemedics Corporation 1.00 USD 0.0%
RadNet, Inc. 1.00 USD 0.0%
Exact Sciences Corporation 127.47 Million USD 100.0%
IDEXX Laboratories, Inc. 380.28 Million USD 100.0%
iSpecimen Inc. - USD -Infinity%
OpGen, Inc. 1.00 USD 0.0%
Exagen Inc. 2.87 Million USD 100.0%
Bionano Genomics, Inc. 22.89 Million USD 100.0%
CareDx, Inc 19.47 Million USD 100.0%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 32.06 Million USD 100.0%
Guardant Health, Inc. 61.94 Million USD 100.0%
Biodesix, Inc. 1.4 Million USD 100.0%
BioNexus Gene Lab Corp. 1.13 Million USD 100.0%
Precipio, Inc. 384 Thousand USD 100.0%
Natera, Inc. 40.75 Million USD 100.0%
Fulgent Genetics, Inc. 5.82 Million USD 100.0%
Sera Prognostics, Inc. - USD -Infinity%
23andMe Holding Co. 12.46 Million USD 100.0%
OPKO Health, Inc. 65.69 Million USD 100.0%
Personalis, Inc. 5.66 Million USD 100.0%
Aclaris Therapeutics, Inc. - USD -Infinity%
Applied DNA Sciences, Inc. 330.02 Thousand USD 100.0%
T2 Biosystems, Inc. 4.81 Million USD 100.0%
Neogen Corporation 189.26 Million USD 100.0%
Myriad Genetics, Inc. 20.1 Million USD 100.0%
ICON Public Limited Company 1.00 USD 0.0%
NeoGenomics, Inc. 24.15 Million USD 100.0%
Star Equity Holdings, Inc. 3.42 Million USD 100.0%
MDxHealth SA 2.77 Million USD 100.0%
Prenetics Global Limited 3.12 Million USD 100.0%
Illumina, Inc. 587 Million USD 100.0%
DarioHealth Corp. 5.06 Million USD 100.0%
ENDRA Life Sciences Inc. 2.62 Million USD 100.0%
Mainz Biomed B.V. 613.63 Thousand USD 100.0%
Trinity Biotech plc 19.93 Million USD 100.0%
Sotera Health Company 51.98 Million USD 100.0%
bioAffinity Technologies, Inc. 18.48 Thousand USD 99.995%